Cervomed to participate in upcoming investor conferences

Boston, sept. 03, 2025 (globe newswire) -- cervomed inc. (nasdaq: crvo), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that company management will participate in the following investor conferences during the month of september:
CRVO Ratings Summary
CRVO Quant Ranking